Zenotech Laboratories Ltd banner
Z

Zenotech Laboratories Ltd
BSE:532039

Watchlist Manager
Zenotech Laboratories Ltd
BSE:532039
Watchlist
Price: 45.5 INR -2.99% Market Closed
Market Cap: ₹2.8B

P/OCF

18.8
Current
38%
Cheaper
vs 3-y average of 30.1

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
18.8
=
Market Cap
₹2.8B
/
Operating Cash Flow
₹144.4m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
18.8
=
Market Cap
₹2.8B
/
Operating Cash Flow
₹144.4m

Valuation Scenarios

Zenotech Laboratories Ltd is trading below its 3-year average

If P/OCF returns to its 3-Year Average (30.1), the stock would be worth ₹72.82 (60% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-9%
Maximum Upside
+60%
Average Upside
30%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 18.8 ₹45.5
0%
3-Year Average 30.1 ₹72.82
+60%
5-Year Average 28 ₹67.61
+49%
Industry Average 17.2 ₹41.46
-9%
Country Average 23 ₹55.45
+22%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
IN
Zenotech Laboratories Ltd
BSE:532039
2.9B INR 18.8 80.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -211 714.7 -160 127.7
US
Abbvie Inc
NYSE:ABBV
351.3B USD 18.5 83.9
US
Amgen Inc
NASDAQ:AMGN
185.7B USD 18.6 24.1
US
Gilead Sciences Inc
NASDAQ:GILD
161.8B USD 16.2 19
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
109.3B USD 30.1 27.6
US
Epizyme Inc
F:EPE
94.1B EUR -531.3 -533.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.4B USD 16 17.6
NL
argenx SE
XBRU:ARGX
41.2B EUR 119.3 37.3
US
Seagen Inc
F:SGT
39.3B EUR -85.8 -61.8
AU
CSL Ltd
ASX:CSL
62.7B AUD 11.9 30.7
P/E Multiple
Earnings Growth PEG
IN
Z
Zenotech Laboratories Ltd
BSE:532039
Average P/E: 40.2
80.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
83.9
97%
0.9
US
Amgen Inc
NASDAQ:AMGN
24.1
20%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
19
16%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.6
19%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.6
14%
1.3
NL
argenx SE
XBRU:ARGX
37.3
30%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
AU
CSL Ltd
ASX:CSL
30.7
9%
3.4

Market Distribution

In line with most companies in India
Percentile
42st
Based on 2 204 companies
42st percentile
18.8
Low
0.5 — 14
Typical Range
14 — 39.7
High
39.7 —
Distribution Statistics
India
Min 0.5
30th Percentile 14
Median 23
70th Percentile 39.7
Max 28 676

Zenotech Laboratories Ltd
Glance View

Market Cap
2.8B INR
Industry
Biotechnology

Zenotech Laboratories Ltd. engages in the manufacture and marketing of pharmaceuticals products. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the business of manufacturing and marketing biotechnology and pharmaceuticals products. The Company’s injectables product portfolio primarily serves niche therapy areas, such as oncology and anesthesiology. The firm has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.

ZENOTECH Intrinsic Value
38.52 INR
Overvaluation 15%
Intrinsic Value
Price ₹45.5
Z
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett